Jeff Bradstreet: Difference between revisions
IntoThinAir (talk | contribs) (edited with ProveIt) |
IntoThinAir (talk | contribs) (edited with ProveIt) |
||
| Line 1: | Line 1: | ||
{{Userspace draft|source=ArticleWizard|date=August 2013}} |
{{Userspace draft|source=ArticleWizard|date=August 2013}} |
||
'''James Jeffrey "Jeff" Bradstreet''', MD, [[FAAFP]] is an American autism researcher who runs the International Child Development Resource Center in [[Melbourne, Florida]]. He has held a Florida medical license since 1984. He obtained his Bachelor of Science degree from the [[University of South Florida]] in 1976 in Natural Sciences, where he also went to medical school beginning three years later. His postgraduate research focused on aerospace medicine, and received his training in this field from [[Wilford Hall Medical Center]]. He is currently an adjunct professor of child development and neuroscience at the [[Southwest College of Naturopathic Medicine]] in [[Tempe, Arizona]].<ref>{{cite web | url=http://www.creationsown.com/aboutus.html | title=About Us | accessdate=24 August 2013}}</ref> A study Bradstreet authored, along with [[Mark Geier]] and David Geier, in the [[Journal of American Physicians and Surgeons]], was cited by [[H. Vasken Aposhian]] during his testimony in the [[autism omnibus trial]], as evidence for Aposhian's hypothesis that autism is caused by a "mercury efflux disorder."<ref>{{cite web | url=http://www.uscfc.uscourts.gov/sites/default/files/autism/OmnibusTrialsTranscripts/cedillo/20070611_cedillo_pps1-298.pdf | title=Transcript of 1st day of autism omnibus trial | publisher=United States Court of Federal Claims | date=11 June 2007 | accessdate=24 August 2013}}</ref>{{rp|99A}} On the other hand, [[Jeffrey Brent]], when testifying on behalf of the government, testified that "It's important to note that much better studies from other investigators could not replicate the results of either the Holmes study or the Bradstreet/Geier study."<ref>{{cite web | url=http://www.uscfc.uscourts.gov/sites/default/files/autism/OmnibusTrialsTranscripts/cedillo/20070622_cedillo_pps2278-2495.pdf | title=Transcript of 10th day of autism omnibus trial | publisher=[[United States Court of Federal Claims]] | date=22 June 2007 | accessdate=24 August 2013}}</ref>{{rp|2351}} Dr. Bradstreet treated a child named Colten Snyder with [[chelation therapy]]. This he did in spite of the fact that, according to Denise Vowell, "The April 29, 2000 hair test for mercury demonstrated a low level of mercury in Colten’s hair, but one within the reference range of normal for the laboratory, and one well below the 90th percentile for U.S. children ages six to eight."<ref name=Quackwatch>{{cite web | url=http://www.quackwatch.org/11Ind/bradstreet.html | title="Autism Specialist" Blasted by Omnibus Special Master | publisher=[[Quackwatch]] | date=15 March 2009 | accessdate=24 August 2013 | author=Barrett, Stephen}}</ref> [[Stephen Barrett]] has stated, "It appears to me that Bradstreet decides which of his nonstandard theories to apply and records diagnoses that embody them."<ref name=Quackwatch/> In an interview with the [[Chicago Tribune]], Bradstreet defended the use of [[intravenous immunoglobulin]] as an autism treatment, saying, "Every kid with autism should have a trial of IVIG if money was not an option and IVIG was abundant."<ref>{{cite web | url=http://articles.chicagotribune.com/2009-11-23/health/chi-autism-science-nov23_1_defeat-autism-autism-recovery-movement-autism-treatment/2 | title=Autism treatment: Science hijacked to support alternative therapies | work=[[Chicago Tribune]] | date=23 November 2009 | accessdate=25 August 2013 | author=Tsouderos, Trine; Callahan, Patricia | pages=2}}</ref> |
'''James Jeffrey "Jeff" Bradstreet''', MD, [[FAAFP]] is an American autism researcher who runs the International Child Development Resource Center in [[Melbourne, Florida]]. He has held a Florida medical license since 1984. He obtained his Bachelor of Science degree from the [[University of South Florida]] in 1976 in Natural Sciences, where he also went to medical school beginning three years later. His postgraduate research focused on aerospace medicine, and received his training in this field from [[Wilford Hall Medical Center]]. He is currently an adjunct professor of child development and neuroscience at the [[Southwest College of Naturopathic Medicine]] in [[Tempe, Arizona]].<ref>{{cite web | url=http://www.creationsown.com/aboutus.html | title=About Us | accessdate=24 August 2013}}</ref> A study Bradstreet authored, along with [[Mark Geier]] and David Geier, in the [[Journal of American Physicians and Surgeons]], was cited by [[H. Vasken Aposhian]] during his testimony in the [[autism omnibus trial]], as evidence for Aposhian's hypothesis that autism is caused by a "mercury efflux disorder."<ref>{{cite web | url=http://www.uscfc.uscourts.gov/sites/default/files/autism/OmnibusTrialsTranscripts/cedillo/20070611_cedillo_pps1-298.pdf | title=Transcript of 1st day of autism omnibus trial | publisher=United States Court of Federal Claims | date=11 June 2007 | accessdate=24 August 2013}}</ref>{{rp|99A}} On the other hand, [[Jeffrey Brent]], when testifying on behalf of the government, testified that "It's important to note that much better studies from other investigators could not replicate the results of either the Holmes study or the Bradstreet/Geier study."<ref>{{cite web | url=http://www.uscfc.uscourts.gov/sites/default/files/autism/OmnibusTrialsTranscripts/cedillo/20070622_cedillo_pps2278-2495.pdf | title=Transcript of 10th day of autism omnibus trial | publisher=[[United States Court of Federal Claims]] | date=22 June 2007 | accessdate=24 August 2013}}</ref>{{rp|2351}} Dr. Bradstreet treated a child named Colten Snyder with [[chelation therapy]]. This he did in spite of the fact that, according to Denise Vowell, "The April 29, 2000 hair test for mercury demonstrated a low level of mercury in Colten’s hair, but one within the reference range of normal for the laboratory, and one well below the 90th percentile for U.S. children ages six to eight."<ref name=Quackwatch>{{cite web | url=http://www.quackwatch.org/11Ind/bradstreet.html | title="Autism Specialist" Blasted by Omnibus Special Master | publisher=[[Quackwatch]] | date=15 March 2009 | accessdate=24 August 2013 | author=Barrett, Stephen}}</ref> [[Stephen Barrett]] has stated, "It appears to me that Bradstreet decides which of his nonstandard theories to apply and records diagnoses that embody them."<ref name=Quackwatch/> In an interview with the [[Chicago Tribune]], Bradstreet defended the use of [[intravenous immunoglobulin]] as an autism treatment, saying, "Every kid with autism should have a trial of IVIG if money was not an option and IVIG was abundant."<ref>{{cite web | url=http://articles.chicagotribune.com/2009-11-23/health/chi-autism-science-nov23_1_defeat-autism-autism-recovery-movement-autism-treatment/2 | title=Autism treatment: Science hijacked to support alternative therapies | work=[[Chicago Tribune]] | date=23 November 2009 | accessdate=25 August 2013 | author=Tsouderos, Trine; Callahan, Patricia | pages=2}}</ref> Bradstreet has also published some research regarding the use of [[hyperbaric oxygen therapy]] for autism.<ref>{{cite pmid|22703610}}</ref> In an article in Autism Science Digest, Bradstreet endorsed [[stem cell therapy]] as an autism treatment, writing, "By natural design, the purpose of stem cells in the brain is regulation, healing, and repair. Biologically, therefore, stem cells appear to be better suited to heal the brain than any other current therapy. No matter how challenging the task of repairing the brain may appear to be, case reports have built an argument for supporting the reversibility of autism using immunological interventions."<ref>{{cite web | url=http://www.emcell.com/shared/files/102423783-Stem-Cells-Autism-One-Year-Later-by-James-Jeffrey-Bradstreet-MD-MD-H-FAAF.pdf?sid=7613c80fdb7dd49df2128cb129005e84 | title=Stem cells and autism: one year later | publisher=Autism One | work=Autism Science Digest | accessdate=25 August 2013}}</ref> |
||
Revision as of 05:18, 25 August 2013
James Jeffrey "Jeff" Bradstreet, MD, FAAFP is an American autism researcher who runs the International Child Development Resource Center in Melbourne, Florida. He has held a Florida medical license since 1984. He obtained his Bachelor of Science degree from the University of South Florida in 1976 in Natural Sciences, where he also went to medical school beginning three years later. His postgraduate research focused on aerospace medicine, and received his training in this field from Wilford Hall Medical Center. He is currently an adjunct professor of child development and neuroscience at the Southwest College of Naturopathic Medicine in Tempe, Arizona.[1] A study Bradstreet authored, along with Mark Geier and David Geier, in the Journal of American Physicians and Surgeons, was cited by H. Vasken Aposhian during his testimony in the autism omnibus trial, as evidence for Aposhian's hypothesis that autism is caused by a "mercury efflux disorder."[2]: 99A On the other hand, Jeffrey Brent, when testifying on behalf of the government, testified that "It's important to note that much better studies from other investigators could not replicate the results of either the Holmes study or the Bradstreet/Geier study."[3]: 2351 Dr. Bradstreet treated a child named Colten Snyder with chelation therapy. This he did in spite of the fact that, according to Denise Vowell, "The April 29, 2000 hair test for mercury demonstrated a low level of mercury in Colten’s hair, but one within the reference range of normal for the laboratory, and one well below the 90th percentile for U.S. children ages six to eight."[4] Stephen Barrett has stated, "It appears to me that Bradstreet decides which of his nonstandard theories to apply and records diagnoses that embody them."[4] In an interview with the Chicago Tribune, Bradstreet defended the use of intravenous immunoglobulin as an autism treatment, saying, "Every kid with autism should have a trial of IVIG if money was not an option and IVIG was abundant."[5] Bradstreet has also published some research regarding the use of hyperbaric oxygen therapy for autism.[6] In an article in Autism Science Digest, Bradstreet endorsed stem cell therapy as an autism treatment, writing, "By natural design, the purpose of stem cells in the brain is regulation, healing, and repair. Biologically, therefore, stem cells appear to be better suited to heal the brain than any other current therapy. No matter how challenging the task of repairing the brain may appear to be, case reports have built an argument for supporting the reversibility of autism using immunological interventions."[7]
References
- ^ "About Us". Retrieved 24 August 2013.
- ^ "Transcript of 1st day of autism omnibus trial" (PDF). United States Court of Federal Claims. 11 June 2007. Retrieved 24 August 2013.
- ^ "Transcript of 10th day of autism omnibus trial" (PDF). United States Court of Federal Claims. 22 June 2007. Retrieved 24 August 2013.
- ^ a b Barrett, Stephen (15 March 2009). ""Autism Specialist" Blasted by Omnibus Special Master". Quackwatch. Retrieved 24 August 2013.
- ^ Tsouderos, Trine; Callahan, Patricia (23 November 2009). "Autism treatment: Science hijacked to support alternative therapies". Chicago Tribune. p. 2. Retrieved 25 August 2013.
{{cite web}}: CS1 maint: multiple names: authors list (link) - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 22703610, please use {{cite journal}} with
|pmid=22703610instead. - ^ "Stem cells and autism: one year later" (PDF). Autism Science Digest. Autism One. Retrieved 25 August 2013.